The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer.
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - QED Therapeutics
 
G. Daniel Grass
No Relationships to Disclose
 
Benjamin L. Maughan
Consulting or Advisory Role - Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Janssen Oncology; Merck; Peloton Therapeutics; Pfizer; Tempus
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Rohit K. Jain
Honoraria - Alphasights (I)
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Pfizer; Seattle Genetics/Astellas; Taiho Oncology (I)
Speakers' Bureau - Gilead Sciences; Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb
 
Christopher B. Dechet
No Relationships to Disclose
 
Alejandro Sanchez
No Relationships to Disclose
 
Brock O Neil
No Relationships to Disclose
 
Michael Adam Poch
No Relationships to Disclose
 
Roger Li
Stock and Other Ownership Interests - crispr therapeutics; Guardant Health
Consulting or Advisory Role - Arquer Diagnostics; Bristol-Myers Squibb; FerGene; Ferring
Research Funding - CG Oncology
Expert Testimony - CG Oncology
Other Relationship - Predicine
 
Shane Lloyd
Honoraria - Sirtex Medical
 
Jonathan David Tward
Consulting or Advisory Role - Bayer; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Scientific Affairs; Merck; Myriad Genetics
Research Funding - Bayer (Inst); Myriad Genetics (Inst)
Expert Testimony - Expert Consulting Services
 
Tenzin Kunsang Phunrab
No Relationships to Disclose
 
Josiah Hawks
No Relationships to Disclose
 
Umang Swami
Consulting or Advisory Role - Seagen
Research Funding - Janssen (Inst); Seattle Genetics/Astellas (Inst)
 
Kenneth M Boucher
No Relationships to Disclose
 
Neeraj Agarwal
No Relationships to Disclose